Phase I
Despite the urgent need for more research into the coronavirus, the New York Times reported on August 14 that there have been numerous testing delays, staffing shortages and space constraints tying up the process.
Shares of Poseida Therapeutics plunged more than 20% in premarket trading this morning after the company announced the U.S. Food and Drug Administration halted a cancer drug trial due to safety concerns.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for August 19, 2020.
The 11-person team at Codagenix may be tiny, but it has big plans for the company’s new COVID-19 vaccine.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for August 17, 2020.
A COVID-19 vaccine candidate developed by Chinese pharmaceutical company Sinopharm triggered antibody-based immune responses in early and mid-stage trials.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for August 14, 2020.
American Gene Technologies (AGT), based in Rockville, Maryland, received the go-ahead from the U.S. Food and Drug Administration (FDA) to begin a Phase I clinical trial of AGT103-T, a gene therapy, to eliminate HIV from infected individuals.
A recent report in the New England Journal of Medicine reveals that the racial and ethnic minority groups most negatively-impacted by COVID-19 are also the least represented in these clinical studies.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for August 12, 2020.
PRESS RELEASES